Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
How It Works Complete Payment Includes physician visit, medication, supplies, and shipping
BMI 24.5 or higher: Eligible if you also have a weight-related health condition
In 2023, semaglutide (the active ingredient in Wegovy & Ozempic) was added to updated PCOS treatment guidance due to its ability to address insulin resistance
Retatrutide An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, demonstrating body-weight change of up to 24.2% in phase 2 trials alongside improvements in cardiometabolic parameters and hepatic steatosis
By keeping track of your blood sugar, A1C levels, and weight, you can see how well the medication is working
Because semaglutide-induced thyroid C-cell tumors have been reported in rodent studies, semaglutide should not be used in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
US$ 23.93
US$ 25.50
US$ 22.29
US$ 26.01
US$ 23.20
US$ 21.38
